Table 7:
Comparison of relative mean improvement as a percentage of baseline score between symptom duration subgroups (n=78)
| PROM scores: | ≤ 60 symptom months (n=50) | > 60 symptom months (n=28) | Test Statistic | p-value |
|---|---|---|---|---|
| RMI (%) | RMI (%) | |||
| SNOT-22 total score | 50.2% | 53.2% | MWU=540 | 0.185 |
| Rhinologic domain | 45.5% | 64.4% | MWU=514 | 0.213 |
| Extra-nasal rhinologic domain | 45.5% | 44.4% | MWU=513 | 0.334 |
| Ear / facial domain | 55.0% | 72.5% | MWU=499 | 0.193 |
| Psychological dysfunction | 39.8% | 68.8% | MWU=459 | 0.098 |
| Sleep dysfunction | 46.1% | 60.4% | MWU=515 | 0.461 |
| RSDI total score | 56.7% | 76.1% | MWU=519 | 0.282 |
| Physical domain | 48.8% | 74.7% | MWU=530 | 0.205 |
| Functional domain | 60.9% | 83.2% | MWU=429 | 0.065 |
| Emotional domain | 34.7% | 73.7% | MWU=367 | 0.166 |
| Endoscopy score | 46.4% | 14.8% | MWU=387 | 0.600 |
| BSIT score | 10.6% | 56.0% | MWU=573 | 0.006 |
PROM, patient reported outcome measure; RMI, relative mean improvement, SNOT-22, 22-item SinoNasal Outcome Test; RSDI, Rhinosinusitis Disability Index; BSIT, Brief Smell Identification Test. MWU, Mann Whitney U test statistic.